Document:

Letter dated September 28, 2006

 Exhibit 10.1 
 [TRACINDA LETTERHEAD] 
 September 28, 2006 
 G. Richard Wagoner, Jr., 
       Chairman and Chief Executive Officer 
 General Motors
Corporation 
 300 Renaissance Center 
 Detroit, Michigan 48265 
 Dear Mr. Wagoner: 
 In keeping with Tracinda’s desire to have an open relationship with General
Motors, we want to let you know that, consistent with statements included in our Schedule 13D filings, Tracinda is interested in acquiring approximately six million shares of GM’s common stock in the open market and may consider acquiring up to
an additional six million shares. 
 As you are aware, because GM owns interest in various insurance, banking, trust and industrial loan
companies, Tracinda could be required to satisfy various state and federal rules and regulations prior to any such acquisition, since it would result in Tracinda owning 10% or more of GM’s outstanding common stock. 
 We are seeking the cooperation and support of the Company and its management in connection with these filings and any related proceedings, as we believe
additional investment by Tracinda in GM would be viewed positively by investors, and your support will maximize the likelihood of obtaining regulatory approval. 
 We welcome the opportunity to discuss this matter further with you if you so desire. 
  

	
	Very truly yours,
	TRACINDA CORPORATION
	
	 /s/ Anthony L. Mandekic

	Anthony L. Mandekic
	Secretary/TreasurerPurchase Agreement

 Exhibit 10(ix)(a) 
 PURCHASE AGREEMENT 
 AMONG 
 BNC BANCORP, 
 BNC CAPITAL TRUST IV 
 AND 
 TWE, LTD., 
  

 Dated as of September 27, 2006

  

  

 PURCHASE AGREEMENT 
 ($7,000,000 TRUST PREFERRED SECURITIES) 
 THIS PURCHASE AGREEMENT, dated as of September 27, 2006, is
entered into among, BNC Bancorp, a North Carolina corporation (the “Company”), BNC Capital Trust IV, a Delaware statutory trust (the “Trust,” and, together with the Company, the “Sellers”), and TWE,
Ltd., an exempted company incorporated under the laws of the Cayman Islands (including any assignee thereof, the “Purchaser”). 
 WITNESSETH: 
 WHEREAS, the Sellers propose to issue and sell 7,000 Floating Rate Preferred Securities of the Trust, having a stated
liquidation amount of $1,000 per preferred security, bearing a variable rate of interest per annum, reset quarterly, equal to LIBOR (as defined in the Indenture (as defined below)) plus 1.70% (the “Preferred Securities”);

 WHEREAS, the entire proceeds from the sale of the Preferred Securities will be combined with the entire proceeds from the sale by the
Trust to the Company of its common securities (the “Common Securities”), and will be used by the Trust to purchase $7,217,000 in principal amount of the unsecured junior subordinated notes of the Company (the “Junior
Subordinated Notes”); 
 WHEREAS, the Preferred Securities and the Common Securities of the Trust will be issued pursuant to the
Amended and Restated Trust Agreement (the “Trust Agreement”), dated as of the Closing Date (as defined below), among the Company, as depositor, Wilmington Trust Company, as property trustee (in such capacity, the “Property
Trustee”), and as Delaware trustee (in such capacity, the “Delaware Trustee”), the Administrative Trustees named therein (in such capacities, the “Administrative Trustees”), and the holders from time to
time of undivided beneficial interests in the assets of the Trust; 
 WHEREAS, the Preferred Securities will be fully and unconditionally
guaranteed on a subordinated basis by the Company with respect to distributions and amounts payable upon liquidation, redemption or repayment (the “Guarantee”) pursuant and subject to the Guarantee Agreement (the “Guarantee
Agreement”), to be dated as of the Closing Date and executed and delivered by the Company and Wilmington Trust Company, as guarantee trustee (the “Guarantee Trustee”), for the benefit from time to time of the holders of the Preferred
Securities; and 
 WHEREAS, the Junior Subordinated Notes will be issued pursuant to a Junior Subordinated Indenture, dated as of the Closing
Date (the “Indenture”), between the Company, and Wilmington Trust Company, as indenture trustee (in such capacity, the “Indenture Trustee”). 
 NOW, THEREFORE, in consideration of the mutual agreements and subject to the terms and conditions herein set forth, the parties hereto agree as follows:

 Section 1. Definitions. The Preferred Securities, the Common Securities and the Junior Subordinated Notes are collectively referred
to herein as the “Securities.” This Purchase Agreement, the Indenture, the Trust Agreement, the Guarantee Agreement and the Securities are collectively referred to herein as the “Operative Documents.” All other
capitalized terms used but not defined in this Purchase Agreement shall have the meanings ascribed thereto in the Indenture. 
  

 2 

 Section 2. Purchase and Sale of the Preferred Securities. 
 2.1 The Sellers agree to sell to the Purchaser, and the Purchaser agrees to purchase from the Sellers, the Preferred Securities for an aggregate amount
(the “Purchase Price”) equal to $7,000,000. In connection with the purchase of the Preferred Securities, the Company shall pay no fee to its introducing agent (the “Introducing Agent”) for services rendered (the
“Fee”). The Purchaser shall be responsible for the following expenses: (i) any rating agency costs and expenses, and (ii) the Fee payable to the Introducing Agent; provided that the Introducing Agent has an agreement with
the Purchaser; but shall not be responsible for any fees and expenses set forth in Section 7 hereof, unless otherwise provided therein. The Trust shall use the Purchase Price, together with the proceeds from the sale of the Common
Securities, to purchase the Junior Subordinated Notes. 
 2.2 Delivery or transfer of, and payment for, the Preferred Securities shall be
made at 11:00 A.M. New York City time, on September 27, 2006, or such later date (not later than October 27, 2006) as the parties may designate (such date and time of delivery and payment for the Preferred Securities being herein called
the “Closing Date”). On the Closing Date, the Preferred Securities shall be transferred and delivered to the Purchaser, or its designee, against the payment of the Purchase Price to the Sellers made by wire transfer in immediately
available funds to a U.S. account designated in writing by the Company. 
 2.3 Delivery of the Preferred Securities shall be made at such
location, and in such names and denominations, as the Purchaser shall designate in advance of the Closing Date. The Company and the Trust agree to have the Preferred Securities available for inspection and checking by the Purchaser in New York, New
York, not later than 2:00 P.M. New York time, on the business day prior to the Closing Date. The closing for the purchase and sale of the Preferred Securities shall occur at the offices of Thacher Proffitt & Wood LLP, Two
World Financial Center, New York, New York 10281, or such other place as the parties hereto shall agree. 
 2.4 The Preferred Securities
shall be sold by the Trust, directly or indirectly, to the Purchaser without registration of any of the Preferred Securities, the Junior Subordinated Notes under the Securities Act of 1933, as amended (the “Securities Act”), or any
other applicable securities laws in reliance upon exemptions from the registration requirements of the Securities Act and other applicable securities laws. The Sellers and the Purchaser have entered into this Agreement to set forth their
understanding as to their relationship and their respective rights, duties and obligations. 
 2.5 Upon original issuance thereof, the
Preferred Securities and Junior Subordinated Notes certificates shall each contain a legend as required pursuant to any of the Operative Documents, including without limitation, a legend stating that the offer, sale or transfer of the Preferred
Securities or the Junior Subordinated Notes, as the case may be, will be made only (a) to the issuer thereof, (b) to a person that the transferor reasonably believe is a “qualified institutional buyer” (as defined in Rule 144A
under the Securities Act) in a transaction meeting the requirements of Rule 144A, or (c) to an institutional “accredited investor” within the 
  

 3 

 meaning of subparagraph (a) (1), (2), (3) or (7) of Rule 501 under the Securities Act that is acquiring
the Preferred Securities or the Junior Subordinated Notes, as the case may be, for its own account, or for the account of such an “accredited investor,” for investment purposes and not with a view to, or for offer or sale in connection
with, any distribution thereof in violation of the Securities Act, in each case in accordance with any applicable securities laws of any state of the United States or any other applicable jurisdiction and, in the case of (c) above, subject to
the right of the Trust and/or the Company, as applicable, to require an opinion of counsel and other information satisfactory to each of them. 
 Section 3. Closing Conditions. The obligations of the parties under this Agreement on the Closing Date are subject to the following conditions: 
 3.1 Accuracy of Representations and Warranties. The representations and warranties contained in this Agreement, and the statements of the Sellers made in any certificates pursuant to this Agreement, shall be
accurate as of the date of delivery of the Preferred Securities. 
 3.2 Opinions of Counsel. On the Closing Date, the Purchaser shall
have received the following favorable opinions or certificate, as the case may be, each dated as of the Closing Date: (a) from Thacher Proffitt & Wood LLP, special counsel for the Purchaser and addressed to the Purchaser
in substantially the form set forth on Exhibit A-1 attached hereto and incorporated herein by this reference, (b) either (i) an opinion from Brooks Pierce McLendon Humphrey & Leonard, counsel for the Sellers, or
(ii) an opinion from the General Counsel or Chief Legal Officer of the Company, or (iii) if the Company does not have a General Counsel or Chief Legal Officer, an Officers’ Certificate from the Chief Executive Officer, President or
Executive Vice President of the Company, and the Chief Financial Officer, Treasurer or Assistant Treasurer of the Company, in each case addressed to the Purchaser in substantially the form set forth on Exhibit A-2 attached hereto and
incorporated herein by this reference, (c) from Thacher Proffitt & Wood LLP, special tax counsel for the Purchaser and addressed to the Purchaser in substantially the form set forth on Exhibit A-3 attached hereto
and incorporated herein by this reference, (d) from Morris, James, Hitchens & Williams LLP, special Delaware counsel to the Trust and addressed to the Purchaser and the Sellers, in substantially the form set forth on Exhibit A-4
attached hereto and incorporated herein by this reference, and (e) from Morris, James, Hitchens & Williams LLP, special counsel to the Indenture Trustee, the Property Trustee, the Delaware Trustee and the Guarantee Trustee and
addressed to the Purchaser and the Sellers, in substantially the form set forth on Exhibit A-5 attached hereto and incorporated herein by this reference. Each certificate or opinion addressed to the Purchaser shall state that the first
entity, if any, to which the Purchaser transfers any of the Preferred Securities, and, if such transferee is a warehouse entity, the next subsequent transferee that is not a warehouse entity (each, a “Subsequent Purchaser”) shall be
entitled to rely on such opinion. 
 3.3 Officer’s Certificate. The Company shall have furnished to the Purchaser a certificate
of the Company, signed by its Chief Executive Officer, President or an Executive Vice President and by the Chief Financial Officer, Treasurer or Assistant Treasurer of the Company, and the Trust shall have furnished to the Purchaser a certificate of
the Trust, signed by an Administrative Trustee of the Trust, in each case dated the Closing Date, and, in the case of the Company, as to 3.3.1 and 3.3.2 below and, in the case of the Trust, as to 3.3.1 below: 
 3.3.1 the representations and warranties in this Agreement are true and correct on and as of the Closing Date with the same effect as if made on the
Closing Date, and the Company and the Trust have complied with all the agreements and satisfied all the conditions on either of their part to be performed or satisfied at or prior to the Closing Date; and 
  

 4 

 3.3.2 since the date of the Interim Financial Statements (as defined below), there has been no material
adverse change in the condition (financial or other), earnings, business, prospects or assets of the Company and its subsidiaries, taken as a whole, whether or not arising from transactions occurring in the ordinary course of business. 

3.4 No Subsequent Change. Subsequent to the execution of this Agreement, there shall not have been any change, or any development involving a
prospective change, in or affecting the condition (financial or other), earnings, business, prospects or assets of the Company and its subsidiaries, whether or not occurring in the ordinary course of business, the effect of which is, in the
Purchaser’s judgment, so material and adverse as to make it impractical or inadvisable to proceed with the purchase of the Preferred Securities. 
 3.5 Purchase Permitted by Applicable Laws; Legal Investment. The purchase of and payment for the Preferred Securities as described in this Agreement shall (a) not be prohibited by any applicable law or
governmental regulation, (b) not subject the Purchaser to any penalty or, in the reasonable judgment of the Purchaser, other onerous conditions under or pursuant to any applicable law or governmental regulation, and (c) be permitted by the
laws and regulations of the jurisdictions to which the Purchaser is subject. 
 3.6 Consents and Permits. The Company and the Trust
shall have received all consents, permits and other authorizations, and made all such filings and declarations, as may be required from any person or entity pursuant to any law, statute, regulation or rule (federal, state, local and foreign), or
pursuant to any agreement, order or decree to which the Company or the Trust is a party or to which either is subject, in connection with the transactions contemplated by this Agreement. 
 3.7 Information. Prior to or on the Closing Date, the Sellers shall have furnished to the Purchaser and its counsel such further information,
certificates, opinions and documents as the Purchaser or its counsel may reasonably request. 
 Each certificate signed by any trustee of the
Trust or any officer of the Company and delivered to the Purchaser or its counsel in connection with the Operative Documents and the transactions contemplated hereby and thereby shall be deemed to be a representation and warranty of the Trust and/or
the Company, as the case may be, and not by such trustee or officer in any individual capacity. 
  

 5 

 Section 4. Representations and Warranties of the Sellers. The Sellers jointly and severally
represent and warrant to the Purchaser as of the date hereof and as of the Closing Date as follows: 
 4.1 Securities Laws Matters:

 (a) Neither the Company nor the Trust, nor any of their “Affiliates” (as defined in Rule 501(b) of Regulation D under the
Securities Act (“Regulation D”)), nor any person acting on any of their behalf (except for the Introducing Agent, as to which neither the Company nor the Trust make any representation) has, directly or indirectly, made offers or
sales of any security, or solicited offers to buy any security, under circumstances that would require the registration under the Securities Act of any of the Securities. 
 (b) Neither the Company nor the Trust, nor any of their Affiliates, nor any person acting on its or their behalf (except for the Introducing Agent, as to which neither the Company nor the Trust make any
representation) has (i) offered for sale or solicited offers to purchase the Securities, (ii) engaged in any form of general solicitation or general advertising (within the meaning of Regulation D) in connection with any offer or sale of
any of the Securities, or (iii) engaged in any “directed selling efforts” within the meaning of Regulation S under the Securities Act (“Regulation S”) with respect to the Securities. 
 (c) The Securities (i) are not and have not been listed on a national securities exchange registered under Section 6 of the Securities Exchange
Act of 1934, as amended (the “Exchange Act”), or quoted on a U.S. automated interdealer quotation system and (ii) are not of an open-end investment company, unit investment trust or face-amount certificate company that are, or
are required to be, registered under Section 8 of the Investment Company Act of 1940, as amended (the “Investment Company Act”), and the Securities otherwise satisfy the eligibility requirements of Rule 144A(d)(3) promulgated
pursuant to the Securities Act (“Rule 144A(d)(3)”). 
 (d) Neither the Company nor the Trust is, and, immediately following
consummation of the transactions contemplated hereby and the application of the net proceeds therefrom, neither the Company nor the Trust will be, an “investment company” or an entity “controlled” by an “investment
company,” in each case within the meaning of Section 3(a) of the Investment Company Act. 
 (e) Neither the Company nor the Trust
has paid or agreed to pay to any person or entity, directly or indirectly, any fees or other compensation for soliciting another to purchase any of the Securities. 
 4.2 Standing and Qualification of the Trust. The Trust has been duly created and is validly existing in good standing as a statutory trust under the Delaware Statutory Trust Act, 12 Del. C. §3801, et
seq. (the “Statutory Trust Act”) with all requisite power and authority to own property and to conduct the business it transacts and proposes to transact and to enter into and perform its obligations under the Operative
Documents to which it is a party. The Trust is duly qualified to transact business as a foreign entity and is in good standing in each jurisdiction in which such qualification is necessary, except where the failure to so qualify or be in good
standing would not have a material adverse effect on the condition (financial or otherwise), earnings, business, prospects or assets of the Trust, whether or not occurring in the ordinary course of business. The Trust is not a party to, or otherwise
bound by, any agreement other than the Operative Documents. The Trust is, and under current law will continue to be, classified for federal income tax purposes as a grantor trust and not as an association or publicly traded partnership taxable as a
corporation. 

 6 

 4.3 Trust Agreement. The Trust Agreement has been duly authorized by the Company and, on the
Closing Date specified in Section 2.2, will have been duly executed and delivered by the Company and the Administrative Trustees of the Trust, and, assuming due authorization, execution and delivery by the Property Trustee and the
Delaware Trustee, will be a legal, valid and binding obligation of the Company and the Administrative Trustees, enforceable against them in accordance with its terms, subject to applicable bankruptcy, insolvency and similar laws affecting
creditors’ rights generally and to general principles of equity. Each of the Administrative Trustees of the Trust is an employee of the Company or one of its subsidiaries and has been duly authorized by the Company to execute and deliver the
Trust Agreement. To the knowledge of the Company and the Trust, the Trust is not in violation of any provision of the Statutory Trust Act. 
 4.4 Guarantee Agreement and the Indenture. The Guarantee Agreement and the Indenture have been duly authorized by the Company and, on the Closing Date, will have been duly executed and delivered by the Company, and, assuming due
authorization, execution and delivery by the Guarantee Trustee, in the case of the Guarantee, and by the Indenture Trustee in the case of the Indenture, will be a legal, valid and binding obligation of the Company enforceable against it in
accordance with its terms, subject to applicable bankruptcy, insolvency and similar laws affecting creditors’ rights generally and to general principles of equity. 
 4.5 Preferred Securities and Common Securities. The Preferred Securities and the Common Securities have been duly authorized by the Trust and, when issued and delivered against payment therefor on the Closing
Date to the Purchaser in accordance with this Agreement, in the case of the Preferred Securities, and to the Company in accordance with the Common Securities Subscription Agreement between the Company and the Trust, dated as of the Closing Date, in
the case of the Common Securities, will be validly issued, fully paid and nonassessable and will represent undivided beneficial interests in the assets of the Trust entitled to the benefits of the Trust Agreement, enforceable against the Trust in
accordance with their terms, subject to applicable bankruptcy, insolvency and similar laws affecting creditors’ rights generally and to general principles of equity. The issuance of the Securities is not subject to preemptive or other similar
rights. On the Closing Date, all of the issued and outstanding Common Securities will be directly owned by the Company free and clear of any pledge, security interest, claim, lien or other encumbrance (each, a “Lien”). 

4.6 Junior Subordinated Notes. The Junior Subordinated Notes have been duly authorized by the Company and, on the Closing Date, will have been
duly executed and delivered to the Indenture Trustee for authentication in accordance with the Indenture and, when authenticated in the manner provided for in the Indenture and delivered to the Trust against payment therefor in accordance with the
Junior Subordinated Note Subscription Agreement between the Company and the Trust, dated as of the Closing Date, will constitute legal, valid and binding obligations of the Company entitled to the benefits of the Indenture enforceable against the
Company in accordance with their terms, subject to applicable bankruptcy, insolvency and similar laws affecting creditors’ rights generally and to general principles of equity. 
 4.7 Purchase Agreement. This Agreement has been duly authorized, executed and delivered by the Company and the Trust and constitutes the legal,
valid and binding obligation of the Company and the Trust, enforceable against the Company and the Trust in accordance with its terms, subject to applicable bankruptcy, insolvency and similar laws affecting creditors’ rights generally and to
general principles of equity. 
  

 7 

 4.8 Defaults. Neither the issue and sale of the Common Securities, the Preferred Securities or the
Junior Subordinated Notes, nor the purchase of the Junior Subordinated Notes by the Trust, the execution and delivery of and compliance with the Operative Documents by the Company or the Trust, to the extent a party thereto, the consummation of the
transactions contemplated herein or therein, or the use of the proceeds therefrom, (i) will conflict with or constitute a breach of, or a default under, the Trust Agreement or the charter or bylaws of the Company or any subsidiary of the
Company or any applicable law, statute, rule, regulation, judgment, order, writ or decree of any government, governmental authority, agency or instrumentality or court, domestic or foreign, having jurisdiction over the Trust or the Company or any of
its subsidiaries, or their respective properties or assets (collectively, “Governmental Entities”), (ii) will conflict with or constitute a violation or breach of, or a default or Repayment Event (as defined below) under, or
result in the creation or imposition of any Lien upon any property or assets of the Trust, the Company or any of its subsidiaries pursuant to any contract, indenture, mortgage, loan agreement, note, lease or other agreement or instrument to which
(A) the Trust, the Company or any of its subsidiaries is a party or by which it or any of them may be bound, or (B) any of the property or assets of any of them is subject, or any judgment, order or decree of any court, Governmental Entity
or arbitrator, except, in the case of this clause (ii), for such conflicts, breaches, violations, defaults, Repayment Events (as defined below) or Liens which (X) would not, singly or in the aggregate, adversely affect the consummation of the
transactions contemplated by the Operative Documents and (Y) would not, singly or in the aggregate, have a material adverse effect on the condition (financial or otherwise), earnings, business, liabilities, prospects and assets (taken as a
whole) or business prospects of the Company and its subsidiaries taken as a whole, whether or not occurring in the ordinary course of business (a “Material Adverse Effect”) or (iii) require the consent, approval, authorization
or order of any court or Governmental Entity. As used herein, a “Repayment Event” means any event or condition which gives the holder of any note, debenture or other evidence of indebtedness (or any person acting on such
holder’s behalf) the right to require the repurchase, redemption or repayment of all or a portion of such indebtedness by the Trust or the Company or any of its subsidiaries prior to its scheduled maturity. 
 4.9 Organization, Standing and Qualification of the Company. The Company has been duly incorporated and is validly existing as a corporation in
good standing under the laws of North Carolina, with all requisite corporate power and authority to own, lease and operate its properties and conduct the business it transacts and proposes to transact, and is duly qualified to transact business and
is in good standing as a foreign corporation in each jurisdiction where the nature of its activities requires such qualification, except where the failure of the Company to be so qualified would not, singly or in the aggregate, have a Material
Adverse Effect. 
 4.10 Subsidiaries of the Company. The Company has no subsidiaries that are material to its business, financial
condition or earnings other than those subsidiaries listed in Schedule I attached hereto (the “Significant Subsidiaries”). Each Significant Subsidiary has been duly organized and is validly existing and in good standing under the
laws of the jurisdiction in which it is chartered or organized, with all requisite power and authority to own its 
  

 8 

 properties and conduct the business it transacts and proposes to transact. Each Significant Subsidiary is duly qualified
to transact business and is in good standing as a foreign entity in each jurisdiction where the nature of its activities requires such qualification, except where the failure of any such Significant Subsidiary to be so qualified would not, singly or
in the aggregate, have a Material Adverse Effect. 
 4.11 Government Licenses; Laws. Each of the Trust, the Company and each of its
subsidiaries hold all necessary approvals, authorizations, orders, licenses, certificates and permits (collectively, “Government Licenses”) of and from Governmental Entities necessary to conduct its respective business as now being
conducted, and neither the Trust, the Company nor any of its subsidiaries has received any notice of proceedings relating to the revocation or modification of any such Government License, except where the failure to be so licensed or approved or the
receipt of an unfavorable decision, ruling or finding, would not, singly or in the aggregate, have a Material Adverse Effect; all of the Government Licenses are valid and in full force and effect, except where the invalidity or the failure of such
Government Licenses to be in full force and effect, would not, singly or in the aggregate, have a Material Adverse Effect; and the Company and its subsidiaries are in compliance with all applicable laws, rules, regulations, judgments, orders,
decrees and consents, except where the failure to be in compliance would not, singly or in the aggregate, have a Material Adverse Effect. 
 4.12 Stock. All of the issued and outstanding shares of capital stock of the Company and each of its subsidiaries are validly issued, fully paid and nonassessable; all of the issued and outstanding capital stock of each subsidiary of
the Company is owned by the Company, directly or through subsidiaries, free and clear of any Lien, claim or equitable right; and none of the issued and outstanding capital stock of the Company or any subsidiary was issued in violation of any
preemptive or similar rights arising by operation of law, under the charter or by-laws of such entity or under any agreement to which the Company or any of its subsidiaries is a party. 
 4.13 Property. Each of the Trust, the Company and each subsidiary of the Company has good and marketable title to all of its respective real and
personal properties, in each case free and clear of all Liens and defects, except for those that would not, singly or in the aggregate, have a Material Adverse Effect; and all of the leases and subleases under which the Trust, the Company or any
subsidiary of the Company holds properties are in full force and effect, except where the failure of such leases and subleases to be in full force and effect would not, singly or in the aggregate, have a Material Adverse Effect and none of the
Trust, the Company or any subsidiary of the Company has any notice of any claim of any sort that has been asserted by anyone adverse to the rights of the Trust, the Company or any subsidiary of the Company under any such leases or subleases, or
affecting or questioning the rights of such entity to the continued possession of the leased or subleased premises under any such lease or sublease, except for such claims that would not, singly or in the aggregate, have a Material Adverse Effect.

 4.14 Conflicts, Authorizations and Approvals. Neither the Company nor any of its subsidiaries is (i) in violation of its
respective charter, bylaws or similar organizational documents or (ii) in default in the performance or observance of any obligation, agreement, covenant or condition contained in any contract, indenture, mortgage, loan agreement, note, lease
or other agreement or instrument to which either the Company or any such subsidiary is a party 
  

 9 

 or by which it or any of them may be bound or to which any of the property or assets of any of them is subject, except,
in the case of clause (ii), where such default would not, singly or in the aggregate, have a Material Adverse Effect. No filing with, or authorization, approval, consent, license, order, registration, qualification or decree of, any Governmental
Entity, other than those that have been made or obtained, is necessary or required for the performance by the Trust or the Company of their respective obligations under the Operative Documents, as applicable, or the consummation by the Trust and the
Company of the transactions contemplated by the Operative Documents. 
 4.15 Holding Company Registration and Deposit Insurance. The
Company is duly registered as a bank holding company under the Bank Holding Company Act of 1956, as amended (the “Bank Holding Company Act”), and the regulations of the Board of Governors of the Federal Reserve System (the
“Federal Reserve”), and the deposit accounts of the Company’s subsidiary depository institutions are insured by the Federal Deposit Insurance Corporation (“FDIC”) to the fullest extent permitted by law and the
rules and regulations of the FDIC, and no proceeding for the termination of such insurance are pending or, to the knowledge of the Company or the Trust after due inquiry, threatened. 
 4.16 Financial Statements. 
 (a) The
audited consolidated financial statements (including the notes thereto) and schedules of the Company and its consolidated subsidiaries at and for the three fiscal years ended December 31, 2005 (the “Financial Statements”) and
the interim unaudited consolidated financial statements of the Company and its consolidated subsidiaries at and for the quarter and six months ended June 30, 2006, (the “Interim Financial Statements”) provided to the Purchaser
are the most recently available audited and unaudited consolidated financial statements of the Company and its consolidated subsidiaries, respectively, and fairly present in all material respects, in accordance with U.S. generally accepted
accounting principles (“GAAP”), the financial position of the Company and its consolidated subsidiaries, and the results of operations and changes in financial condition as of the dates and for the periods therein specified,
subject, in the case of Interim Financial Statements, to year-end adjustments (which are expected to consist solely of normal recurring adjustments). Such consolidated financial statements and schedules have been prepared in accordance with GAAP
consistently applied throughout the periods involved (except as otherwise noted therein). 
 (b) The Company’s report on FRY-9C, dated
June 30, 2006 (the “FRY-9C”), provided to the Purchaser is the most recently available such report, and the information therein fairly presents in all material respects the financial position of the Company and its
subsidiaries. None of the Company or any of its subsidiaries has been requested by a Governmental Entity to republish, restate or refile any regulatory or financial report. 
 (c) Since the respective dates of the Financial Statements and Interim Financial Statements and the FRY-9C, there has not been (A) any material
adverse change or development with respect to the condition (financial or otherwise), earnings, business, assets or business prospects of the Company and its subsidiaries, taken as a whole, whether or not occurring in the ordinary course of business
or (B) any dividend or distribution of any kind declared, paid or made by the Company on any class of its capital stock other than regular quarterly dividends on the Company’s common stock. 
  

 10 

 (d) The accountants of the Company who certified the Financial Statements are independent public
accountants of the Company and its subsidiaries within the meaning of the Securities Act and the rules and regulations of the Securities and Exchange Commission (“SEC”) thereunder. 
 4.17 Regulatory Enforcement Matters. None of the Trust, the Company nor any of its subsidiaries, nor any of their respective officers, directors,
employees or representatives, is subject or is party to, or has received any notice from any Regulatory Agency (as defined below) that any of them will become subject or party to any investigation with respect to, any cease-and-desist order,
agreement, civil monetary penalty, consent agreement, memorandum of understanding or other regulatory enforcement action, proceeding or order with or by, or is a party to any commitment letter or similar undertaking to, or is subject to any
directive by, or has been a recipient of any supervisory letter from, or has adopted any board resolutions at the request or suggestion of, any Regulatory Agency that, in any such case, currently restricts in any material respect the conduct of
their business or that in any material manner relates to their capital adequacy, their credit policies, their management or their business (each, a “Regulatory Action”), nor has the Trust, the Company or any of its subsidiaries been
advised by any Regulatory Agency that it is considering issuing or requesting any such Regulatory Action; and there is no unresolved violation, criticism or exception by any Regulatory Agency with respect to any report or statement relating to any
examinations of the Trust, the Company or any of its subsidiaries, except where such unresolved violation, criticism or exception would not, singly or in the aggregate, have a Material Adverse Effect. If the Company is a bank holding company that is
subject to the Bank Holding Company Act, it is a “well-run” bank holding company that satisfies the criteria of the Federal Reserve’s regulations at 12 C.F.R. §225.14(c). Each of the Company’s subsidiaries that is a
depository institution, the accounts of which are insured by the FDIC (i) is “well-capitalized” within the meaning of 12 U.S.C. §1831o and applicable implementing regulations thereunder; and (ii) is not, and has not been
notified by any Regulatory Agency that it is, in “troubled condition” within the meaning of 12 U.S.C. §1831i and applicable implementing regulations thereunder. As used herein, the term “Regulatory Agency” means any federal
or state agency charged with the supervision or regulation of depository institutions or holding companies of depository institutions, or engaged in the insurance of depository institution deposits, or any court, administrative agency or commission
or other governmental agency, authority or instrumentality having supervisory or regulatory authority with respect to the Trust, the Company or any of its subsidiaries. 
 4.18 No Undisclosed Liabilities. None of the Trust, the Company nor any of its subsidiaries has any material liability, whether known or unknown, whether asserted or unasserted, whether absolute or contingent,
whether accrued or unaccrued, whether liquidated or unliquidated, and whether due or to become due, including any liability for taxes (and there is no past or present fact, situation, circumstance, condition or other basis for any present or future
action, suit, proceeding, hearing, charge, complaint, claim or demand against the Company or its subsidiaries that could give rise to any such liability), except for (i) liabilities set forth in the Financial Statements or the Interim Financial
Statements and (ii) normal fluctuations in the amount of the liabilities referred to in clause (i) above occurring in the ordinary course of business of the Trust, the Company and all of its subsidiaries since the date of the most recent
balance sheet included in such Financial Statements. 
  

 11 

 4.19 Litigation. There is no action, suit or proceeding before or by any Governmental Entity,
arbitrator or court, domestic or foreign, now pending or, to the knowledge of the Company or the Trust after due inquiry, threatened against or affecting the Trust or the Company or any of its subsidiaries, except for such actions, suits or
proceedings that, if adversely determined, would not, singly or in the aggregate, adversely affect the consummation of the transactions contemplated by the Operative Documents or have a Material Adverse Effect; and the aggregate of all pending legal
or governmental proceedings to which the Trust or the Company or any of its subsidiaries is a party or of which any of their respective properties or assets is subject, including ordinary routine litigation incidental to the business, are not
expected to result in a Material Adverse Effect. 
 4.20 No Labor Disputes. No labor dispute with the employees of the Trust, the
Company or any of its subsidiaries exists or, to the knowledge of the executive officers of the Trust or the Company, is imminent, except those which would not, singly or in the aggregate, have a Material Adverse Effect. 
 4.21 Filings with the SEC. The documents of the Company filed with the SEC in accordance with the Exchange Act, from and including the
commencement of the fiscal year covered by the Company’s most recent Annual Report on Form 10-K, at the time they were or hereafter are filed by the Company with the SEC (collectively, the “1934 Act Reports”), complied and will
comply in all material respects with the requirements of the Exchange Act and the rules and regulations of the SEC thereunder (the “1934 Act Regulations”), and did not, and, at the date of this Agreement and on the Closing Date, do
not and will not include an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading;
and other than such instruments, agreements, contracts and other documents as are filed as exhibits to the Company’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q or Current Reports on Form 8-K, there are no instruments,
agreements, contracts or documents of a character described in Item 601 of Regulation S-K promulgated by the SEC to which the Company or any of its subsidiaries is a party. The Company is in compliance with all currently applicable
requirements of the Exchange Act and the 1934 Act Regulations that were added by the Sarbanes-Oxley Act of 2002. 
 4.22 Deferral of
Interest Payments on Junior Subordinated Notes. The Company has no present intention to exercise its option to defer payments of interest on the Junior Subordinated Notes as provided in the Indenture. The Company believes that the likelihood
that it would exercise its rights to defer payments of interest on the Junior Subordinated Notes as provided in the Indenture at any time during which the Junior Subordinated Notes are outstanding is remote because of the restrictions that would be
imposed on the Company’s ability to declare or pay dividends or distributions on, or to redeem, purchase, acquire or make a liquidation payment with respect to, any of the Company’s capital stock and on the Company’s ability to make
any payments of principal, interest or premium on, or repay, repurchase or redeem, any of its debt securities that rank pari passu in all respects with or junior in interest to the Junior Subordinated Notes. 
  

 12 

 4.23 Tax Returns. The Company and each of the Significant Subsidiaries have timely and duly filed
all Tax Returns (defined below) required to be filed by them, and all such Tax Returns are true, correct and complete in all material respects. The Company and each of the Significant Subsidiaries have timely and duly paid in full all material Taxes
required to be paid by them (whether or not such amounts are shown as due on any Tax Return). There are no federal, state, or other Tax audits or deficiency assessments proposed or pending with respect to the Company or any of the Significant
Subsidiaries, and no such audits or assessments are threatened. As used herein, the terms “Tax” or “Taxes” mean (i) all federal, state, local, and foreign taxes, and other assessments of a similar nature
(whether imposed directly or through withholding), including any interest, additions to tax, or penalties applicable thereto, imposed by any Governmental Entity, and (ii) all liabilities in respect of such amounts arising as a result of being a
member of any affiliated, consolidated, combined, unitary or similar group, as a successor to another person or by contract. As used herein, the term “Tax Returns” means all federal, state, local, and foreign Tax returns,
declarations, statements, reports, schedules, forms, and information returns and any amendments thereto filed or required to be filed with any Governmental Entity. 
 4.24 Taxes. The Trust is not subject to United States federal income tax with respect to income received or accrued on the Junior Subordinated Notes, interest payable by the Company on the Junior Subordinated
Notes is deductible by the Company, in whole or in part, for United States federal income tax purposes, and the Trust is not, or will not be within ninety (90) days of the date hereof, subject to more than a de minimis amount of other
taxes, duties or other governmental charges. There are no rulemaking or similar proceedings before the United States Internal Revenue Service or comparable federal, state, local or foreign government bodies which involve or affect the Company or any
subsidiary, which, if the subject of an action unfavorable to the Company or any subsidiary, could result in a Material Adverse Effect. 
 4.25 Books and Records. The books, records and accounts of the Company and its subsidiaries accurately and fairly reflect, in reasonable detail, the transactions in, and dispositions of, the assets of, and the results of operations
of, the Company and its subsidiaries. The Company and each of its subsidiaries maintains a system of internal accounting controls sufficient to provide reasonable assurances that (i) transactions are executed in accordance with
management’s general or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP and to maintain asset accountability, (iii) access to assets is
permitted only in accordance with management’s general or specific authorization and (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to
any differences. 
 4.26 Insurance. The Company and the Significant Subsidiaries are insured by insurers of recognized financial
responsibility against such losses and risks and in such amounts in all material respects as are customary in the businesses in which they are engaged or propose to engage after giving effect to the transactions contemplated hereby, including, but
not limited to, real or personal property owned or leased against theft, damage, destruction, act of vandalism and all other risks customarily insured against. All policies of insurance and fidelity or surety bonds insuring the Company or any of the
Significant Subsidiaries, the Company’s or Significant Subsidiaries’ respective businesses, assets, employees, officers and directors are in full force and 
  

 13 

 effect. The Company and each of the Significant Subsidiaries are in compliance with the terms of such policies and
instruments in all material respects. Neither the Company nor any Significant Subsidiary has reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from
similar insurers as may be necessary to continue its business at a cost that would not have a Material Adverse Effect. Within the past twelve months, neither the Company nor any Significant Subsidiary has been denied any insurance coverage which it
has sought or for which it has applied. 
 4.27 Corporate Funds. The Company and its subsidiaries or any person acting on behalf of
the Company and its subsidiaries including, without limitation, any director, officer, agent or employee of, the Company or its subsidiaries has not, directly or indirectly, while acting on behalf of the Company and its subsidiaries (i) used
any corporate funds for unlawful contributions, gifts, entertainment or other unlawful expenses relating to political activity; (ii) made any unlawful payment to foreign or domestic government officials or employees or to foreign or domestic
political parties or campaigns from corporate funds; (iii) violated any provision of the Foreign Corrupt Practices Act of 1977, as amended; or (iv) made any other unlawful payment. 
 4.28 OSHA Compliance. Neither the Company nor any of its subsidiaries is in violation of any federal or state law or regulation relating to
occupational safety and health and the Company and its subsidiaries have received all permits, licenses or other approvals required of them under applicable federal and state occupational safety and health and environmental laws and regulations to
conduct their respective businesses, and the Company and each of its subsidiaries is in compliance with all terms and conditions of any such permit, license or approval, except any such violation of law or regulation, failure to receive required
permits, licenses or other approvals or failure to comply with the terms and conditions of such permits, licenses or approvals which would not, singly or in the aggregate result in a Material Adverse Effect. 
 4.29 Information. The information provided by the Company and the Trust pursuant to this Agreement does not, as of the date hereof, and will not,
as of the Closing Date, contain any untrue statement of a material fact or omit to state any material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading. 
 Section 5. Representations and Warranties of the Purchaser. The Purchaser represents and warrants to, and agrees with, the Company and the
Trust as follows: 
 5.1 The Purchaser understands and acknowledges that the Preferred Securities, the Junior Subordinated Notes and the
Guarantee (i) have not been registered under the Securities Act, or any other applicable securities law, (ii) are being offered for sale by the Trust or the Company, as the case may be, in transactions not requiring registration under the
Securities Act and (iii) may not be offered, sold, pledged or otherwise transferred by the Purchaser except in compliance with the registration requirements of the Securities Act or any other applicable securities laws, pursuant to an exemption
therefrom or in a transaction not subject thereto. 
  

 14 

 5.2 The Purchaser is purchasing the Preferred Securities for its own account and not with a view to, or
for offer or sale in connection with, any distribution thereof in violation of the Securities Act or other applicable securities laws, subject to any requirement of law that the disposition of its property be at all times within its control and
subject to its ability to resell such Preferred Securities pursuant to an effective registration statement under the Securities Act or under Rule 144A or any other exemption from registration available under the Securities Act or any other
applicable securities law. The Purchaser understands that no public market exists for any of the Preferred Securities, and that it is unlikely that a public market will ever exist for the Preferred Securities. 
 5.3 The Purchaser represents and warrants that (a) it has consulted with its own legal, regulatory, tax, business, investment, financial and
accounting advisers in connection herewith to the extent it has deemed necessary; (b) it has had a reasonable opportunity to ask questions of and receive answers from officers and representatives of the Sellers concerning their respective
financial condition and results of operations and the purchase of the Preferred Securities and any such questions have been answered to its satisfaction; (c) it has had the opportunity to review all publicly available records and filings
concerning the Sellers and it has carefully reviewed such records and filings that it considers relevant to making an investment decision; and (d) it has made its own investment decisions based upon its own judgment, due diligence and advice
from such advisers as it has deemed necessary and not upon any view expressed by the Sellers. 
 5.4 The Purchaser is (i) an
institutional “accredited investor” within the meaning of subparagraph (a)(1), (2), (3) or (7) of Rule 501 of Regulation D under the Securities Act, and (ii) a “qualified institutional buyer” within the meaning of
Rule 144A under the Securities Act. 
 Section 6. Covenants of the Sellers. The Sellers covenant and agree with the Purchaser as
follows: 
 6.1 Compliance with Representations and Warranties. During the period from the date of this Agreement to the Closing Date,
the Sellers shall use their best efforts and take all action necessary or appropriate to cause their representations and warranties contained in Section 4 hereof to be true as of the Closing Date, after giving effect to the transactions
contemplated by this Agreement, as if made on and as of the Closing Date. 
 6.2 Sale and Registration of Securities. Neither the
Company nor the Trust will, nor will either of them permit any of their Affiliates to, nor will any of them permit any person acting on its or their behalf (other than the Introducing Agent and its affiliates) to, directly or indirectly,
(i) resell any Preferred Securities that have been acquired by any of them, (ii) sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in the Securities Act) that would or could be
integrated with the sale of the Preferred Securities in any manner that would require the registration of the Securities under the Securities Act or (iii) make offers or sales of any such Security, or solicit offers to buy any such Security,
under any circumstances that would require the registration of any of such Securities under the Securities Act. 
  

 15 

 6.3 Clearing and Settlement. The Company and the Trust will cooperate with the Purchaser (or any
holder of the Preferred Securities) and use all commercially reasonable efforts to make the Preferred Securities eligible for clearance and settlement as book-entry securities through the facilities of the Depository Trust Company
(“DTC”) and listed for trading through the PORTAL Market (“PORTAL”), and will execute, deliver and comply with all representations made to, and agreements with, DTC and PORTAL. This Section 6.3 will
survive delivery of and payment for the Preferred Securities. 
 6.4 Integration. Neither the Company nor the Trust will, until one
hundred eighty (180) days following the Closing Date, without the Purchaser’s prior written consent, offer, sell, contract to sell, grant any option to purchase or otherwise dispose of, directly or indirectly, (i) any Preferred
Securities or other securities of the Trust other than as contemplated by this Agreement or (ii) any other securities convertible into, or exercisable or exchangeable for, any Preferred Securities or other securities of the Trust. 

6.5 Qualification of Securities. The Company and the Trust will arrange for the qualification of the Preferred Securities for sale under the
laws of such jurisdictions as the Purchaser may designate and will maintain such qualifications in effect so long as required for the sale of the Preferred Securities. The Company or the Trust, as the case may be, will promptly advise the Purchaser
of the receipt by the Company or the Trust, as the case may be, of any notification with respect to the suspension of the qualification of the Preferred Securities for sale in any jurisdiction or the initiation or threatening of any proceeding for
such purpose. 
 6.6 Use of Proceeds. The Trust shall use the proceeds from the sale of the Preferred Securities and the Common
Securities to purchase the Junior Subordinated Notes from the Company. 
 6.7 Investment Company. So long as any of the Securities are
outstanding, (i) the Securities shall not be listed on a national securities exchange registered under Section 6 of the Exchange Act or quoted in a U.S. automated interdealer quotation system, (ii) neither the Company nor the Trust
shall be an open-end investment company, unit investment trust or face-amount certificate company that is, or is required to be, registered under Section 8 of the Investment Company Act, and, the Securities shall otherwise satisfy the
eligibility requirements of Rule 144A(d)(3) and (iii) neither the Company nor the Trust shall engage, or permit any subsidiary to engage, in any activity which would cause it or any subsidiary to be an “investment company” under the
provisions of the Investment Company Act. 
 6.8 Solicitation and Advertising. Neither the Company nor the Trust will, nor will either
of them permit any of their Affiliates or any person acting on their behalf (other than the Introducing Agent and its affiliates), to (i) engage in any “directed selling efforts” within the meaning of Regulation S under the Securities
Act or (ii) engage in any form of “general solicitation or general advertising” (within the meaning of Regulation D) in connection with any offer or sale of any of the Securities. 
 6.9 Compliance with Rule 144A(d)(4) under the Securities Act. So long as any of the Securities are outstanding and are “restricted
securities” within the meaning of Rule 144(a)(3) under the Securities Act, the Sellers will, during any period in which they are not 
  

 16 

 subject to and in compliance with Section 13 or 15(d) of the Exchange Act, or the Sellers are not exempt from such
reporting requirements pursuant to and in compliance with Rule 12g3-2(b) under the Exchange Act, provide to each holder of such restricted securities and to each prospective purchaser (as designated by such holder) of such restricted securities,
upon the request of such holder or prospective purchaser in connection with any proposed transfer, any information required to be provided by Rule 144A(d)(4) under the Securities Act, if applicable. The information provided by the Sellers pursuant
to this Section 6.9 will not, at the date thereof, contain any untrue statement of a material fact or omit to state any material fact necessary to make the statements therein, in light of the circumstances under which they were made, not
misleading. If the Company and the Trust are required to register under the Exchange Act, such reports filed in compliance with Rule 12g3-2(b) shall be sufficient information as required above. This covenant is intended to be for the benefit of the
Purchaser, the holders of the Securities, and the prospective purchasers designated by such holders, from time to time, of the Securities. 
 6.10 Reports. The Company shall furnish to (i) the Purchaser and any subsequent holder of the Securities, and (ii) any beneficial owner of the Securities reasonably identified to the Company (which identification may be
made by either such beneficial owner or by the Purchaser), a duly completed and executed certificate in the form attached hereto as Exhibit B, including the financial statements referenced in such Exhibit, which certificate and financial
statements shall be so furnished by the Company or the Trust not later than forty-five (45) days after the end of each of the first three fiscal quarters of each fiscal year of the Company and not later than ninety (90) days after the end
of each fiscal year of the Company. 
 Section 7. Payment of Expenses. The Company hereby covenants and agrees that it shall pay
or cause to be paid (directly or by reimbursement) all costs and expenses incident to the performance of the obligations of the Sellers under this Agreement, whether or not the transactions contemplated herein are consummated or this Agreement is
terminated, including (i) all costs and expenses incident to the authorization, issuance, sale and delivery of the Preferred Securities and any taxes payable in connection therewith; (ii) the fees and expenses of qualifying the Preferred
Securities under the securities laws of the several jurisdictions as provided in Section 6.5; (iii) the fees and expenses of the counsel, the accountants and any other experts or advisors retained by the Company or the Trust, which
counsel fees and expenses incurred in connection with the closing of the transactions contemplated hereby, in an amount up to $10,000, shall be reimbursed by the Purchaser on the Closing Date; and (iv) the fees and all reasonable expenses of
the Guarantee Trustee, the Property Trustee, the Delaware Trustee, the Indenture Trustee and any other trustee or paying agent appointed under the Operative Documents, except for any acceptance fee and annual administrative fees of any such trustee
and the fees and disbursements of counsel to such trustees incurred in connection with the closing of the transactions contemplated hereby, which shall be paid by the Purchaser on the Closing Date. 
  

 17 

 Section 8. Indemnification & Contribution. 
 8.1 Indemnification. 
 8.1.1 The
Company and the Trust agree jointly and severally to indemnify and hold harmless the Purchaser, a Subsequent Purchaser and their respective affiliates (collectively, the “Indemnified Parties”) and the Indemnified Parties’
respective directors, officers, employees and agents and each person who “controls” the Indemnified Parties within the meaning of either the Securities Act or the Exchange Act against any and all losses, claims, damages or liabilities,
joint or several, to which they or any of them may become subject under the Securities Act, the Exchange Act or other federal or state statutory law or regulation, at common law or otherwise, insofar as such losses, claims, damages or liabilities
(or actions in respect thereof) arise out of or are based upon (i) any untrue statement or alleged untrue statement of a material fact contained in any information or documents furnished or made available to the Purchaser by or on behalf of the
Company, (ii) the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, or (iii) the breach or alleged breach of any representation, warranty
or agreement of either Seller contained herein, and agrees to reimburse each such Indemnified Party, as incurred, for any legal or other expenses reasonably incurred by them in connection with investigating or defending any such loss, claim, damage,
liability or action. This indemnity agreement will be in addition to any liability which the Company or the Trust may otherwise have. 
 8.1.2
Promptly after receipt by an Indemnified Party under this Section 8 of notice of the commencement of any action, such Indemnified Party will, if a claim in respect thereof is to be made against the indemnifying party under this
Section 8, promptly notify the indemnifying party in writing of the commencement thereof; but the failure so to notify the indemnifying party (i) will not relieve the indemnifying party from liability under Section 8.1.1
above unless and to the extent that such failure results in the forfeiture by the indemnifying party of material rights and defenses and (ii) will not, in any event, relieve the indemnifying party from any obligations to any Indemnified Party
other than the indemnification obligation provided in Section 8.1.1 above. The Purchaser shall be entitled to appoint counsel to represent the Indemnified Party in any action for which indemnification is sought. An indemnifying party may
participate at its own expense in the defense of any such action; provided, however, that counsel to the indemnifying party shall not (except with the consent of the Indemnified Party) also be counsel to the Indemnified Party. In no event shall the
indemnifying parties be liable for fees and expenses of more than one counsel (in addition to any local counsel) separate from their own counsel for all Indemnified Parties in connection with any one action or separate but similar or related actions
in the same jurisdiction arising out of the same general allegations or circumstances. An indemnifying party will not, without the prior written consent of the Indemnified Parties, settle or compromise or consent to the entry of any judgment with
respect to any pending or threatened claim, action, suit or proceeding in respect of which indemnification may be sought hereunder (whether or not the Indemnified Parties are actual or potential parties to such claim, action, suit or proceeding)
unless such settlement, compromise or consent includes an unconditional release of each Indemnified Party from all liability arising out of such claim, action, suit or proceeding. 
  

 18 

 8.2 Contribution. 
 8.2.1 In order to provide for just and equitable contribution in circumstances under which the indemnification provided for in Section 8.1 hereof is for any reason held to be unenforceable for the benefit
of an Indemnified Party in respect of any losses, liabilities, claims, damages or expenses referred to therein, then each indemnifying party shall contribute to the aggregate amount of such losses, liabilities, claims, damages and expenses incurred
by such Indemnified Party, as incurred, (i) in such proportion as is appropriate to reflect the relative benefits received by the Sellers, on the one hand, and the Purchaser, on the other hand, from the offering of the Securities or
(ii) if the allocation provided by clause (i) is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative benefits referred to in clause (i) above, but also the relative fault of
the Sellers, on the one hand, and the Purchaser, on the other hand, in connection with the statements, omissions or breaches, which resulted in such losses, liabilities, claims, damages or expenses, as well as any other relevant equitable
considerations. 
 8.2.2 The relative benefits received by the Sellers, on the one hand, and the Purchaser, on the other hand, in connection
with the offering of the Securities shall be deemed to be in the same respective proportions as the total net proceeds from the offering of the Securities (net of the Fee but before deducting expenses) received by the Sellers and the Fee paid by the
Purchaser bear to the aggregate of such net proceeds and the Fee. 
 8.2.3 The Sellers and the Purchaser agree that it would not be just and
equitable if contribution pursuant to this Section 8.2 were determined by pro rata allocation or by any other method of allocation which does not take account of the equitable considerations referred to above in this
Section 8.2. The aggregate amount of losses, liabilities, claims, damages and expenses incurred by an Indemnified Party and referred to above in this Section 8.2 shall be deemed to include any legal or other expenses
reasonably incurred by such Indemnified Party in investigating, preparing or defending against any litigation, or any investigation or proceeding by any governmental agency or body, commenced or threatened, or any claim whatsoever based upon any
such untrue or alleged untrue statement, omission or alleged omission or breach or alleged breach. 
 8.2.4 Notwithstanding any provision of
this Section 8 to the contrary, the Purchaser shall not be required to contribute any amount in excess of the amount of the Fee. 
 8.2.5 No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. 

8.2.6 For purposes of this Section 8.2, each person, if any, who controls the Purchaser within the meaning of Section 15 of the
Securities Act or Section 20 of the Exchange Act and the respective partners, directors, officers, employees and agents of the Purchaser or any such controlling person shall have the same rights to contribution as the Purchaser, while each
officer and director of the Company, each trustee of the Trust and each person, if any, who controls the Company within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act shall have the same rights to
contribution as the Sellers. 
  

 19 

 8.3 Additional Remedies. The indemnity and contribution agreements contained in this
Section 8 are in addition to any liability that the Sellers may otherwise have to any Indemnified Party. 
 8.4 Additional
Indemnification. The Company shall indemnify and hold harmless the Trust against all loss, liability, claim, damage and expense whatsoever, as due from the Trust under Sections 8.1 through 8.3 hereof. 
 Section 9. Rights and Responsibilities of Purchaser. 
 9.1 Reliance. In performing its duties under this Agreement, the Purchaser shall be entitled to rely upon any notice, signature or writing which it shall in good faith believe to be genuine and to be signed or
presented by a proper party or parties. The Purchaser may rely upon any opinions or certificates or other documents delivered by the Sellers or their counsel or designees to the Purchaser. 
 9.2 Rights of Purchaser. In connection with the performance of its duties under this Agreement, the Purchaser shall not be liable for any error of
judgment or any action taken or omitted to be taken unless the Purchaser was grossly negligent or engaged in willful misconduct in connection with such performance or non-performance. No provision of this Agreement shall require the Purchaser to
expend or risk its own funds or otherwise incur any financial liability in connection with the performance of any of its duties hereunder. 
 Section 10. Termination. This Agreement shall be subject to termination in the absolute discretion of the Purchaser, by notice given to the Company and the Trust prior to delivery of and payment for the Preferred Securities, if
prior to such time (i) a downgrading shall have occurred in the rating accorded the Company’s debt securities or preferred stock by any “nationally recognized statistical rating organization,” as that term is used by the SEC in
Rule 15c3-1(c)(2)(vi)(F) under the Exchange Act, or such organization shall have publicly announced that it has under surveillance or review, with possible negative implications, its rating of the Company’s debt securities or preferred stock,
(ii) the Trust shall be unable to sell and deliver to the Purchaser at least $7,000,000 stated aggregate liquidation value of Preferred Securities, (iii) the Company or any of its subsidiaries that is an insured depository institution
shall cease to be “adequately-capitalized” within the meaning of 12 U.S.C. Section 1831 and applicable regulations adopted thereunder, or any formal administrative or judicial action is taken by any appropriate federal banking agency
against the Company or any such insured subsidiary for unsafe and unsound banking practices, or violations of law, (iv) a suspension or material limitation in trading in securities generally shall have occurred on the New York Stock Exchange,
(v) a suspension or material limitation in trading in any of the Company’s securities shall have occurred on the exchange or quotation system upon which the Company’s securities are traded, if any, (vi) a general moratorium on
commercial banking activities shall have been declared either by federal or North Carolina authorities or (vii) there shall have occurred any outbreak or escalation of hostilities, or declaration by the United States of a national emergency or
war or other calamity or crisis the effect of which on financial markets is such as to make it, in the Purchaser’s judgment, impracticable or inadvisable to proceed with the offering or delivery of the Preferred Securities. 
  

 20 

 Section 11. Miscellaneous. 
 11.1 Disclosure Schedule. The term “Disclosure Schedule,” as used herein, means the schedule, if any, attached to this Agreement
that sets forth items the disclosure of which is necessary or appropriate as an exception to one or more representations or warranties contained in Section 4 hereof. The Disclosure Schedule shall be arranged in paragraphs corresponding
to the section numbers contained in Section 4. Nothing in the Disclosure Schedule shall be deemed adequate to disclose an exception to a representation or warranty made herein unless the Disclosure Schedule identifies the exception with
reasonable particularity and describes the relevant facts in reasonable detail. Without limiting the generality of the immediately preceding sentence, the mere listing (or inclusion of a copy) of a document or other item in the Disclosure Schedule
shall not be deemed adequate to disclose an exception to a representation or warranty made herein unless the representation or warranty has to do with the existence of the document or other item itself. Information provided by the Company in
response to any due diligence questionnaire shall not be deemed part of the Disclosure Schedule and shall not be deemed to be an exception to one or more representations or warranties contained in Section 4 hereof unless such information
is specifically included on the Disclosure Schedule in accordance with the provisions of this Section 11.1. 
 11.2
Notices. All communications hereunder will be in writing and effective only on receipt, and will be mailed, delivered by hand or courier or sent by facsimile and confirmed: 
 If to the Purchaser, to: 
 TWE, Ltd. 
 c/o Maples Finance Limited 
 P.O. Box 1093 GT 
 Queensgate House 
 South Church Street 
 George Town 
 Grand Cayman, Cayman Islands 
 Facsimile: (345) 945-7100 
 Telephone: (345) 945-7099 
 Attention: The Directors 
 with a copy to: 
 Thacher Proffitt &
Wood LLP 
 Two World Financial Center 
 New York, New York 10281 
 Facsimile: (212) 912-7751 
 Telephone: (212) 912-7400 
 Attention: Mark I. Sokolow, Esq. 
  

 21 

 if to the Sellers, to: 
 BNC Bancorp 
 BNC Capital Trust IV 
 831 Julian Avenue 
 Thomasville, North Carolina 27630 
 Facsimile: (336) 476-9200 
 Telephone: (336) 476-2052 
 Attention: Chief Financial Officer 
 with a
copy to: 
 Brooks, Pierce, McLendon, Humphrey & Leonard LLP 
 2000 Renaissance Plaza 
 Post Office Box 26000 
 Greensboro, NC 27420 
 Facsimile: (336) 232-9171 
 Telephone: (828) 295-0577 
 Attention: Jean Brooks 
 All such notices and communications shall be deemed to have been duly given (i) at the time delivered by hand, if personally delivered,
(ii) five business days after being deposited in the mail, postage prepaid, if mailed, (iii) when answered back, if telexed, (iv) the next business day after being telecopied, or (v) the next business day after timely delivery to
a courier, if sent by overnight air courier guaranteeing next-day delivery. From and after the Closing, the foregoing notice provisions shall be superseded by any notice provisions of the Operative Documents under which notice is given. The
Purchaser, the Sellers, and their respective counsel, may change their respective notice addresses, from time to time, by written notice to all of the foregoing persons. 
 11.3 Parties in Interest, Successors and Assigns. This Agreement will inure to the benefit of and be binding upon the parties hereto and their respective successors and permitted assigns. Nothing expressed or
mentioned in this Agreement is intended or shall be construed to give any person other than the parties hereto and the affiliates, directors, officers, employees, agents and controlling persons referred to in Section 8 hereof, their
successors, assigns, heirs and legal representatives, and any Subsequent Purchaser, any right or obligation hereunder. None of the rights or obligations of the Company or the Trust under this Agreement may be assigned, whether by operation of law or
otherwise, without the Purchaser’s prior written consent. The rights and obligations of the Purchaser under this Agreement may be assigned without the Company’s or the Trust’s consent; provided that the assignee assumes the
obligations of the Purchaser under this Agreement. 
 11.4 Recourse Limited. No recourse shall be had to any subscriber, officer,
director, employee, trustee, equity holder, certificate holder, incorporator or agent of the Purchaser or its successors or assigns for any obligations hereunder. The Sellers, severally and jointly, further agree (i) not to take any action in
respect of any claims hereunder against any subscriber, officer, director, employee, trustee, equity holder, certificate holder, incorporator or agent of the Purchaser or any of its successors or assigns that is an investment vehicle issuing
collateralized debt obligations and (ii) not to institute against any successor or assign of the 

 22 

 Purchaser that is an investment vehicle issuing collateralized debt obligations any insolvency, bankruptcy,
reorganization, liquidation or similar proceedings in any jurisdiction until one year and one day or, if longer, the applicable preference period then in effect, as the case may be, shall have elapsed since the final payments to the holders of the
securities issued by such investment vehicle. 
 11.5 Amendments. This Agreement may not be modified, amended, altered or
supplemented, except upon the execution and delivery of a written agreement by each of the parties hereto. 
 11.6 Counterparts and
Facsimile. This Agreement may be executed by any one or more of the parties hereto in any number of counterparts, each of which shall be deemed to be an original, but all such counterparts shall together constitute one and the same instrument.
This Agreement may be executed by any one or more of the parties hereto by facsimile which shall be effective as delivery of a manually executed counterpart hereof. 
 11.7 Headings. The headings in this Agreement are for convenience of reference only and shall not limit or otherwise affect the meaning hereof. 
 11.8 Governing Law. THIS AGREEMENT WILL BE GOVERNED BY AND CONSTRUED AND ENFORCED IN ACCORDANCE WITH THE LAW OF THE STATE OF NEW YORK WITHOUT
REFERENCE TO PRINCIPLES OF CONFLICTS OF LAW (OTHER THAN SECTION 5-1401 OF THE GENERAL OBLIGATIONS LAW). 
 11.9 Submission to
Jurisdiction. ANY LEGAL ACTION OR PROCEEDING BY OR AGAINST ANY PARTY HERETO OR WITH RESPECT TO OR ARISING OUT OF THIS AGREEMENT MAY BE BROUGHT IN OR REMOVED TO THE COURTS OF THE STATE OF NEW YORK, IN AND FOR THE COUNTY OF NEW YORK, OR OF THE
UNITED STATES OF AMERICA FOR THE SOUTHERN DISTRICT OF NEW YORK (IN EACH CASE SITTING IN THE BOROUGH OF MANHATTAN). BY EXECUTION AND DELIVERY OF THIS AGREEMENT, EACH PARTY ACCEPTS, FOR ITSELF AND IN RESPECT OF ITS PROPERTY, GENERALLY AND
UNCONDITIONALLY, THE JURISDICTION OF THE AFORESAID COURTS (AND COURTS OF APPEALS THEREFROM) FOR LEGAL PROCEEDINGS ARISING OUT OF OR IN CONNECTION WITH THIS AGREEMENT. 
 11.10 Attorneys’ and Other Professionals’ Fees. Notwithstanding anything in this Agreement to the contrary and notwithstanding statutory provisions governing the collection of attorneys’ fees,
whenever the Company is required to pay the attorneys’ fees of any other Person, the Company shall not be required to pay such attorneys’ fees which exceed those computed using the then applicable hourly billing rates of the attorneys and
other professionals involved multiplied by the hours worked by such individuals; the foregoing shall in no way limit any obligation of the Company to pay such individuals’ reasonable expenses and disbursements incurred in connection therewith.

 11.11 Entire Agreement. This Agreement, together with the Operative Documents and the other documents delivered in connection with
the transactions contemplated 
  

 23 

 by this Agreement, is intended by the parties as a final expression of their agreement and intended to be a complete and
exclusive statement of the agreement and understanding of the parties hereto in respect of the subject matter contained herein and therein. There are no restrictions, promises, warranties or undertakings, other than those set forth or referred to
herein and therein. This Agreement, together with the Operative Documents and the other documents delivered in connection with the transaction contemplated by this Agreement, supersedes all prior agreements and understandings between the parties
with respect to such subject matter. 
 11.12 Severability. In the event that any one or more of the provisions contained herein, or
the application thereof in any circumstances, is held invalid, illegal or unenforceable in any respect for any reason, the validity, legality and enforceability of any such provision in every other respect and of the remaining provisions hereof
shall not be in any way impaired or affected, it being intended that all of the Purchaser’s rights and privileges shall be enforceable to the fullest extent permitted by law. 
 11.13 Survival. The respective agreements, representations, warranties, indemnities and other statements of the Company and the Trust and their
respective officers or trustees and of the Purchaser set forth in or made pursuant to this Agreement will remain in full force and effect, regardless of any investigation made by or on behalf of the Purchaser, the Company or the Trust or any of
their respective officers, directors, trustees or controlling persons, and will survive delivery of and payment for the Preferred Securities. The provisions of Sections 2.1, 7 and 8 shall survive the termination or cancellation
of this Agreement. 
 Signatures appear on the following page 
  

 24 

 IN WITNESS WHEREOF, this Purchase Agreement has been entered
into as of the date first written above. 
  

			
	BNC BANCORP
		
	By:	 	 /s/ W. Swope Montgomery, Jr.

	Name:	 	W. Swope Montgomery, Jr.
	Title:	 	President and CEO
	
	BNC CAPITAL TRUST IV
	By: BNC Bancorp, as Depositor
		
	By:	 	 /s/ W. Swope Montgomery, Jr.

	Name:	 	W. Swope Montgomery, Jr.
	Title:	 	President and CEO

  

			
	TWE, Ltd., as Purchaser,
	 By: Trapeza Capital Management, LLC as
 Portfolio Manager

		
	By:	 	 /s/ John M. Stein

	Name:	 	John M. Stein
	Title:	 	Managing Director

  

 25 

 Schedule I 
 List of Significant Subsidiaries 
 Bank of North Carolina 
  

 26 

 EXHIBIT A-1 
 FORM OF THACHER PROFFITT & WOOD LLP OPINION 
 Pursuant to Section 3.2(a) of the Purchase
Agreement, Thacher Proffitt & Wood LLP, special counsel for the Purchaser, shall deliver an opinion to the effect that: 
  

	(i)	the Company and each Significant Subsidiary is validly existing as a corporation in good standing under the laws of the jurisdiction in which it is chartered or organized;

  

	(ii)	the Company has corporate power and authority to (a) execute and deliver, and to perform its obligations under, the Operative Documents to which it is a party and
(b) issue and perform its obligations under the Notes; 

  

	(iii)	neither the issue and sale of the Common Securities, the Preferred Securities or the Junior Subordinated Notes, nor the purchase by the Trust of the Junior Subordinated Notes, nor
the execution and delivery of, and compliance with, the Operative Documents to which each is a party by, the Company or the Trust, nor the consummation of the transactions contemplated thereby will constitute a breach or violation of the Trust
Agreement or the charter or by-laws of the Company; 

  

	(iv)	the Amended and Restated Trust Agreement has been duly authorized, executed and delivered by the Company and duly executed and delivered by the Administrative Trustees;

  

	(v)	each of the Guarantee and the Indenture has been duly authorized, executed and delivered by the Company and, assuming it has been duly authorized, executed and delivered by the
Guarantee Trustee and the Indenture Trustee, respectively, constitutes a legal, valid and binding obligation of the Company, enforceable against the Company in accordance with its terms, subject to applicable bankruptcy, insolvency and similar laws
affecting creditors’ rights generally and to general principles of equity; 

  

	(vi)	the Junior Subordinated Notes have been duly authorized and executed by the Company and delivered to the Indenture Trustee for authentication in accordance with the Indenture and,
when authenticated in accordance with the provisions of the Indenture and delivered to the Trust against payment therefor, will constitute legal, valid and binding obligations of the Company entitled to the benefits of the Indenture and enforceable
against the Company in accordance with their terms, subject to applicable bankruptcy, insolvency and similar laws affecting creditors’ rights generally and to general principles of equity; 

  

	(vii)	the Trust is not, and, following the issuance of the Preferred Securities and the consummation of the transactions contemplated by the Operative Documents and the application of the
proceeds therefrom, the Trust will not be, an “investment company” or an entity “controlled” by an “investment company,” in each case within the meaning of the Investment Company Act; 

  

	(viii)	assuming (a) the accuracy of the representations and warranties, and compliance with the agreements contained in the Purchase Agreement and (b) that the Preferred
Securities are sold in a manner contemplated by, and in accordance with the Purchase Agreement and the Amended and Restated Trust Agreement, it is not necessary in connection with the 

  

 A-1-1 

 offer, sale and delivery of the Preferred Securities by the Trust to the Purchaser, to register any of
the Securities under the Securities Act or to require qualification of the Indenture under the Trust Indenture Act of 1939, as amended; 
  

	(ix)	the Purchase Agreement has been duly authorized, executed and delivered by the Company and the Trust; and, 

  

	(x)	the Indenture constitutes a valid and binding instrument of the Indenture Trustee, enforceable against the Indenture Trustee in accordance with its terms, except as
rights to indemnity and contribution thereunder may be limited under applicable law or public policy, and subject to the qualifications that (i) enforcement thereof may be limited by bankruptcy, insolvency, receivership, reorganization,
liquidation, voidable preference, moratorium or other laws (including the laws of fraudulent conveyance and transfer) or judicial decisions affecting the enforcement of creditors’ rights generally or the reorganization of financial institutions
and (ii) the enforceability of the Indenture Trustee’s obligations thereunder is subject to general principles of equity (regardless of whether such enforceability is considered in a proceeding in equity or at law) and to the effect of
certain laws and judicial decisions upon the availability and enforceability of certain remedies, including the remedies of specific performance and self-help. 

 In rendering such opinions, such counsel may (A) state that its opinion is limited to the laws of the State of New York, the Delaware General Corporation Law and the federal laws of the United States;
(B) as to matters involving the application of laws of any jurisdiction other than the State of New York and the Delaware General Corporation Law or the federal laws of the United States, (i) rely, to the extent deemed proper and
specified in such opinion, upon the opinion of other counsel of good standing believed to be reliable and who are satisfactory to the Purchaser or (ii) assume such law is substantially similar to the law of the State of New York and,
(C) as to matters of fact, rely to the extent deemed proper, on certificates of responsible officers of the Company and public officials. 
  

 A-1-2 

 EXHIBIT A-2 
 FORM OF COMPANY COUNSEL OPINION 
 OR OFFICERS’ CERTIFICATE 
 Pursuant to Section 3.2(b) of the Purchase Agreement, either (i) counsel for the Company shall deliver an opinion, or (ii) the [General
Counsel/Chief Legal Officer] of the Company shall deliver an opinion, or, (iii) if the Company does not have a General Counsel or Chief Legal Officer, the Chief Executive Officer/President/Executive Vice President and Chief Financial
Officer/Treasurer/Assistant Treasurer of the Company shall provide an Officers’ Certificate, to the effect that: 
  

	(i)	all of the issued and outstanding shares of capital stock of each Significant Subsidiary are owned of record by the Company, and the issuance of the Preferred Securities and the
Common Securities is not subject to any contractual preemptive rights known to such officer; 

  

	(ii)	no consent, approval, authorization or order of any court or governmental authority is required for the issue and sale of the Common Securities, the Preferred Securities or the
Junior Subordinated Notes, the purchase by the Trust of the Junior Subordinated Notes, the execution and delivery of and compliance with the Operative Documents by the Company or the Trust or the consummation of the transactions contemplated in the
Operative Documents, except such approvals (specified in such [opinion/certificate]) as have been obtained; 

  

	(iii)	to the knowledge of such [counsel/officer], there is no action, suit or proceeding before or by any government, governmental instrumentality, arbitrator or court, domestic or
foreign, now pending or threatened against or affecting the Trust or the Company or any Significant Subsidiary that could adversely affect the consummation of the transactions contemplated by the Operative Documents or could have a Material Adverse
Effect; 

  

	(iv)	the Company is duly registered as a bank holding company under the Bank Holding Company Act and the regulations thereunder of the Federal Reserve Board, and the deposit
accounts of the Company’s banking subsidiary are insured by the FDIC to the fullest extent permitted by law and the rules and regulations of the FDIC, and no proceeding for the termination of such insurance are pending or, to such person’s
knowledge, threatened; 

  

	(v)	The execution, delivery and performance of the Operative Documents, as applicable, by the Company and the Trust and the consummation by the Company and the Trust of the transactions
contemplated by the Operative Documents, as applicable, (a) will not result in any violation of the charter or bylaws of the Company, the charter or bylaws of any Significant Subsidiary, the Amended and Restated Trust Agreement or the
Certificate of Trust, and (b) will not conflict with, or result in a breach of any of the terms or provisions of, or constitute a default (or an event which, with notice or lapse of time or both, would constitute a default) under, or result in
the creation or imposition of any lien, charge and encumbrance upon any assets or properties of the Company or any Significant Subsidiary under, (A) any agreement, indenture, mortgage or instrument that the Company or any Significant Subsidiary
is a party to or by which it may be bound or to which any of its 

  

 A-2-1 

 assets or properties may be subject, or (B) any existing applicable law, rule or administrative
regulation [for General Counsel only: except that I express no opinion with respect to the securities laws of the State of Delaware] of any court or governmental agency or authority having jurisdiction over the Company or any Significant Subsidiary
or any of their respective assets or properties, except in case of (b), where any such violation, conflict, breach, default, lien, charge or encumbrance, would not have a material adverse effect on the assets, properties, business, results of
operations or financial condition of the Company and its subsidiaries, taken as whole. 
 All terms used but not defined herein shall have
the meanings assigned to them in the Purchase Agreement. A Subsequent Purchaser shall be entitled to rely on this [opinion/certificate]. 
 [Applies only to in-house counsel opinion] [In rendering such opinions, such counsel may (A) state that the above is limited to the laws of the States of [Jurisdiction of bar admission], (B) rely as to matters of fact, to the
extent deemed proper, on certificates of responsible officers of the Company and public officials.] 
  

 A-2-2 

 EXHIBIT A-3 
 FORM OF TAX COUNSEL OPINION 
 Pursuant to Section 3.2(c) of the Purchase Agreement, Thacher
Proffitt & Wood LLP, special tax counsel for the Purchaser, shall deliver an opinion to the effect that: 
  

	(i)	the Trust will be classified for United States federal income tax purposes as a grantor trust and not as an association or a publicly traded partnership taxable as a corporation;
and 

  

	(ii)	for United States federal income tax purposes, the Junior Subordinated Notes will constitute indebtedness of the Company. 

 In rendering such opinions, such counsel may (A) state that its opinion is limited to the laws of the State of New York and the federal laws of
the United States and (B) rely as to matters of fact, to the extent deemed proper, on certificates of responsible officers of the Company and public officials. 
  

 A-3-1 

 EXHIBIT A-4 
 FORM OF DELAWARE COUNSEL TRUST OPINION 
 Pursuant to Section 3.2(d) of the Purchase Agreement, Morris,
James, Hitchens & Williams LLP, special Delaware counsel for the Trust, shall deliver an opinion to the effect that: 
  

	(i)	The Trust has been duly created and is validly existing in good standing as a statutory trust under the Delaware Statutory Trust Act, and all filings required under the laws of the
State of Delaware with respect to the creation and valid existence of the Trust as a statutory trust have been made. 

  

	(ii)	Under the Delaware Statutory Trust Act and the Amended and Restated Trust Agreement, the Trust has the trust power and authority (i) to own property and conduct its business,
all as described in the Amended and Restated Trust Agreement, (ii) to execute and deliver, and to perform its obligations under, each of the Purchase Agreement, the Common Securities Subscription Agreement, the Junior Subordinated Note
Subscription Agreement, the Preferred Securities and the Common Securities, and (iii) to purchase and hold the Junior Subordinated Notes. 

  

	(iii)	Under the Delaware Statutory Trust Act, the certificate attached to the Amended and Restated Trust Agreement as Exhibit C is an appropriate form of certificate to evidence ownership
of the Preferred Securities. The Preferred Securities have been duly authorized by the Amended and Restated Trust Agreement and, when issued in accordance with the Amended and Restated Trust Agreement and delivered against payment therefor in
accordance with the Amended and Restated Trust Agreement and the Purchase Agreement, the Preferred Securities will be validly issued and (subject to the qualifications set forth in this paragraph) fully paid and nonassessable and will represent
undivided beneficial interests in the assets of the Trust, and the Preferred Security Holders will be entitled to the benefits of the Amended and Restated Trust Agreement. The Preferred Security Holders as beneficial owners of the Trust, will be
entitled to the same limitation of personal liability extended to stockholders of private corporations for profit organized under the General Corporation Law of the State of Delaware. The Preferred Security Holders may be obligated to make payments
or provide indemnity or security as set forth in the Amended and Restated Trust Agreement. 

  

	(iv)	The Common Securities have been duly authorized by the Amended and Restated Trust Agreement and, when issued in accordance with the Amended and Restated Trust Agreement and
delivered against payment therefor in accordance with the Amended and Restated Trust Agreement and the Common Securities Subscription Agreement, will be validly issued and will represent undivided beneficial interests in the assets of the Trust, and
the Common Security Holder will be entitled to the benefits of the Amended and Restated Trust Agreement. 

  

	(v)	Under the Delaware Statutory Trust Act and the Amended and Restated Trust Agreement, the issuance of the Preferred and the Common Securities is not subject to preemptive or other
similar rights. 

  

 A-4-1 

	(vi)	Under the Delaware Statutory Trust Act and the Amended and Restated Trust Agreement, the execution and delivery by the Trust of the Purchase Agreement, the Common Securities
Subscription Agreement and the Junior Subordinated Note Subscription Agreement, and the performance by the Trust of its obligations thereunder, have been duly authorized by all necessary trust action on the part of the Trust.

  

	(vii)	The Amended and Restated Trust Agreement constitutes a legal, valid and binding obligation of the Company and the Trustees, enforceable against the Company and the Trustees in
accordance with its terms. 

  

	(viii)	The issuance and sale by the Trust of the Preferred Securities and the Common Securities, the purchase by the Trust of the Junior Subordinated Notes, the execution, delivery and
performance by the Trust of the Purchase Agreement, the Common Securities Subscription Agreement and the Junior Subordinated Note Subscription Agreement, the consummation by the Trust of the transactions contemplated by the Purchase Agreement, the
Common Securities Subscription Agreement and the Junior Subordinated Note Subscription Agreement, and compliance by the Trust with its obligations thereunder are not prohibited by (i) the Certificate of Trust or the Amended and Restated Trust
Agreement, or (ii) any law or regulation of the State of Delaware applicable to the Trust. 

  

	(ix)	No filing with, or authorization, approval, consent, license, order, registration, qualification or decree of, any Delaware court or Delaware governmental authority or Delaware
agency is required solely in connection with the issuance and sale by the Trust of the Trust Securities, the purchase by the Trust of the Junior Subordinated Notes, the execution, delivery and performance by the Trust of the Purchase Agreement, the
Common Securities Subscription Agreement and the Junior Subordinated Note Subscription Agreement, the consummation by the Trust of the transactions contemplated by the Purchase Agreement, and compliance by the Trust with its obligations thereunder.

  

	(x)	The Preferred Security Holders (other than those Preferred Security Holders who reside or are domiciled in the State of Delaware) will have no liability for income taxes imposed by
the State of Delaware solely as a result of their participation in the Trust and the Trust will not be liable for any income tax imposed by the State of Delaware. 

 In rendering such opinions, such counsel may (A) state that its opinion is limited to the laws of the State of Delaware and (B) rely as to
matters of fact, to the extent deemed proper, on certificates of responsible officers of the Company and public officials. 
  

 A-4-2 

 EXHIBIT A-5 
 FORM OF TRUSTEE COUNSEL OPINION 
 Pursuant to Section 3.2(e) of the Purchase Agreement, Morris, James,
Hitchens & Williams LLP, special counsel for the Property Trustee, the Guarantee Trustee, the Delaware Trustee and the Indenture Trustee, shall deliver an opinion to the effect that: 
  

	(i)	Wilmington Trust Company is duly incorporated and validly existing as a Delaware banking corporation in good standing under the laws of the State of Delaware with trust powers and
its principal place of business in the State of Delaware. 

  

	(ii)	Wilmington Trust Company has requisite corporate power and authority to execute and deliver, and to perform its obligations under, the Amended and Restated Trust Agreement, the
Guarantee Agreement and the Indenture. 

  

	(iii)	The execution, delivery, and performance by Wilmington Trust Company of the Amended and Restated Trust Agreement, the Guarantee Agreement and the Indenture have been duly authorized
by all necessary corporate action on the part of Wilmington Trust Company, and the Amended and Restated Trust Agreement, the Guarantee Agreement and the Indenture have been duly executed and delivered by Wilmington Trust Company.

  

	(iv)	The Amended and Restated Trust Agreement is a legal, valid and binding obligation of Wilmington Trust Company, enforceable against Wilmington Trust Company, in accordance with its
terms. 

  

	(v)	No approval, authorization or other action by, or filing with, any governmental authority or agency under any law or regulation of the State of Delaware or the United States of
America governing the trust powers of Wilmington Trust Company is required solely in connection with the execution, delivery and performance by Wilmington Trust Company of the Amended and Restated Trust Agreement, the Guarantee Agreement and the
Indenture, except for the filing of the Certificate of Trust with the Secretary of State, which Certificate of Trust has been duly filed with the Secretary of State. 

  

	(vi)	The execution, delivery and performance of the Amended and Restated Trust Agreement, the Guarantee Agreement and the Indenture by Wilmington Trust Company are not prohibited by
(i) the Charter or Bylaws of Wilmington Trust Company, (ii) any law or regulation of the State of Delaware or the United States of America governing the trust powers of Wilmington Trust Company, or (iii) to our knowledge (based and
relying solely on the Officer Certificates), any agreements or instruments to which Wilmington Trust Company is a party or by which Wilmington Trust Company is bound or any judgment or order applicable to Wilmington Trust Company.

  

	(vii)	The Junior Subordinated Notes delivered on the date hereof have been authenticated by due execution thereof and delivered by Wilmington Trust Company, as Indenture Trustee, in
accordance with the Company Order. The Preferred Securities delivered on the date hereof have been authenticated by due execution thereof and delivered by Wilmington Trust Company, as Property Trustee, in accordance with the Trust Order.

  

 A-5-1 

 In rendering such opinions, such counsel may (A) state that its opinion is limited to the laws of
the State of Delaware and the federal laws of the United States governing the trust powers of Wilmington Trust Company and (B) rely as to matters of fact, to the extent deemed proper, on certificates of responsible officers of Wilmington
Trust Company and public officials. 
  

 B-4-2 

 Exhibit B 
 FORM OF OFFICER’S CERTIFICATE 
 The undersigned, the [Chief Financial Officer] [Treasurer] [Executive
Vice President] hereby certifies, pursuant to Section 6.10 of the Purchase Agreement, dated as of September 27, 2006, that as of
                    , 20     the Company had the following ratios and balances: 
 BANK HOLDING COMPANY 
 As of [Quarterly Financial Dates] 
  

					
	 Tier 1 Risk Weighted Assets
	 		 	            %
	 Ratio of Double Leverage
	 		 	            %
	 Non-Performing Assets to Loans and OREO
	 		 	            %
	 Tangible Common Equity as a Percentage of Tangible Assets
	 		 	            %
	 Ratio of Reserves to Non-Performing Loans
	 		 	            %
	 Ratio of Net Charge-Offs to Loans
	 		 	            %
	 Return on Average Assets (annualized)
	 		 	            %
	 Net Interest Margin (annualized)
	 		 	            %
	 Efficiency Ratio
	 		 	            %
	 Ratio of Loans to Assets
	 		 	            %
	 Ratio of Loans to Deposits
	 		 	            %
	 Double Leverage (exclude trust preferred as equity)
	 		 	            %
	 Total Assets
	 	$	 	            
	 Year to Date Income
	 	$	 	            

	*	A table describing the quarterly report calculation procedures is attached. 

 [FOR FISCAL YEAR END: Attached hereto are the audited consolidated financial statements (including the balance sheet, income statement and statement of cash flows, and notes thereto, together with the report of the independent accountants
thereon) of the Company and its consolidated subsidiaries for the three years ended                     , 20    .]

 [FOR FISCAL QUARTER END: Attached hereto are the unaudited consolidated and consolidating financial statements (including the balance sheet and income
statement) of the Company and its consolidated subsidiaries for the fiscal quarter and [six/nine] month period ended             , 20    .] 
  

 B-1 

 The financial statements fairly present in all material respects, in accordance with U.S. generally accepted accounting
principles (“GAAP”), the financial position of the Company and its consolidated subsidiaries, and the results of operations and changes in financial condition as of the date, and for the [     quarter interim]
[annual] period ended                     , 20    , and such financial statements have been prepared in accordance
with GAAP consistently applied throughout the period involved (expect as otherwise noted therein). 
 IN WITNESS WHEREOF, the undersigned has
executed this Officer’s Certificate as of this                     day of
                    , 20     
  

			
	  

	Name:	 	 
	Title:	 	
	BNC Bancorp
	831 Julian Avenue
	Thomasville, North Carolina 27360
	(336) 476-9200

  

 B-2 

 FINANCIAL DEFINITIONS 
 BANK HOLDING COMPANY 
  

					
	 Report Item
	  	 Corresponding FRY-9C or LP Line Items with Line
 Item corresponding Schedules
	  	 Description of Calculation

	Tier 1 Risk Weighted Assets	  	 BHCK7206
 Schedule HC-R
	  	Tier 1 Risk Ratio: Core Capital (Tier 1)/ Risk-Adjusted Assets
			
	 Ratio of Double
 Leverage
	  	 (BHCP0365)/(BCHCP3210)
 Schedule PC in the
LP
	  	Total equity investments in subsidiaries divided by the total equity capital. This field is calculated at the parent company level. “Subsidiaries” include bank, bank holding company,
and non-bank subsidiaries.
			
	 Non-Performing Assets to Loans
 and OREO
	  	(BHCK5525-BHCK3506+BHCK5526-BHCK3507+BHCK2744/(BHCK2122+BHCK2744) Schedules HC-C, HC-M & HC-N	  	Total Nonperforming Assets (NPLs+Foreclosed Real Estate+Other Nonaccrual & Repossessed Assets)/Total Loans+Foreclosed Real Estate
			
	Tangible Common Equity as a Percentage of Tangible Assets	  	 (BHDM3210-BHCK3163)/(BHCK2170-BHCK3163)
 Schedule
HC
	  	(Equity Capital – Goodwill)/(Total Assets – Goodwill)
			
	 Ratio of Reserves
 to Non-Performing
Loans
	  	 (BHCK3123+BHCK3128)/(BHCK5525-BHCK3506+BHCK5526-BHCK3507)
 Schedules HC & HC-N & HC-R
	  	Total Loan Loss and Allocated Transfer Risk Reserves/ Total Nonperforming Loans (Nonaccrual + Restructured)
			
	Ratio of Net Charge-Offs to Loans	  	 (BHCK4635-BHCK4605)/(BHCK3516)
 Schedules HI-B &
HC-K
	  	Net charge offs for the period as a percentage of average loans.
			
	Return on Average Assets (annualized)	  	 (BHCK4340/BHCK3368)
 Schedules HI &
HC-K
	  	Net Income as a percentage of Assets.
			
	Net Interest Margin (annualized)	  	 (BHCK4519/(BHCK3515+BHCK3365+BHCK3516+
 BHCK3401+BHCKB985)
 Schedules HI Memorandum and HC-K
	  	(Net Interest Income Fully Taxable Equivalent, if available/Average Earning Assets)
			
	Efficiency Ratio	  	 (BHCK4093)/(BHCK4519+BHCK4079)
 Schedule
HI
	  	(Non-interest Expense)/(Net Interest Income Fully Taxable Equivalent, if available, plus Non-interest Income)
			
	Ratio of Loans to Assets	  	 (BHCKB528+BHCK5369)/(BHCK2170)
 Schedule
HC
	  	Total Loans & Leases (Net of Unearned Income & Gross of Reserve)/Total Assets
			
	Ratio of Loans to Deposits	  	 (BHCKB528+BHCK5369)/(BHDM6631+BHDM6636+BHFN6631+BHFN6636)
 Schedule HC
	  	Total Loans & Leases (Net of Unearned Income & Gross of Reserve)/Total Deposits (Includes Domestic and Foreign Deposits)

  

 1 

					
			
	Total Assets	  	 (BHCK2170)
 Schedule HC
	  	The sum of total assets. Includes cash and balances due from depository institutions; securities; federal funds sold and securities purchased under agreements to resell; loans and lease
financing receivables; trading assets; premises and fixed assets; other real estate owned; investments in unconsolidated subsidiaries and associated companies; customer’s liability on acceptances outstanding; intangible assets; and other
assets.

  

 2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00110-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00110-of-00352.parquet"}]]